EMA: HMPC Meeting Report published

Recommendation
7/8 October 2025
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
On 27 November, 2017, the EMA's Committee on Herbal Medicinal Products (HMPC) published the HMPC meeting report about their meeting held from 20-21 November, 2017.
One of the meeting's key issues was the reflection paper on "Polycyclic Aromatic Hydrocarbons".
The HMPC decided for the comments received on reflection paper EMA/HMPC/300551/2015 to be published. HMPC approves the step-by-step approach suggested by the participants. The parties involved agreed to collect and share data.
Presently, the data available on contamination levels in herbal medicinal products is still very limited and therefore inadequate to serve as a basis for specific requirements and standardised controls. HMPC will also consider requirements from the food sector when determining limits for updating quality guidelines for herbal medicines in the future.
It was further decided by the HMPC that the Q&A document on herbal medicinal products is to be supplemented by a question on the difference between European monographs on herbal medicines and the individual "Product SmPCs".
For more deailed information please see the comprehensive "HMPC meeting report on European Union herbal monographs, guidelines and other activities" as well as the Herbal medicinal products: questions and answers.
Related GMP News
15.09.2025USP-NF Stimuli Article on Apex Vessels used in Dissolution Testing: Corrected Version Published
27.08.2025FDA Warning Letter: Missing Identity Tests, Unverified CoAs, and Inadequate DEG/EG Controls
20.08.2025USP Responds to Comments on Chapter <202> HPTLC Identification of Fixed Oils
13.08.2025USP publishes Comments rereived on Chapter <317>
13.08.2025FDA Issues Warning Letter to Contract Testing Laboratory for Inadequate OOS Investigations
06.08.2025EMA publishes Overview of Comments received on ICH M13B Guideline on Bioequivalence